Positive Readouts, High Bar: Why the Market Faded GPCR
Phase 3 is years away, GI side effects appeared at active amylin doses, and the oral GLP-1 bar is already high.
Already have an account? Sign in.
Phase 3 is years away, GI side effects appeared at active amylin doses, and the oral GLP-1 bar is already high.
Cerebras expects $940–960M in 2026 revenue as it expands capacity to support a $20B OpenAI contract and new hyperscaler agreements.
Cisco shares rose after beating estimates with record revenue and raising its AI hyperscaler target to $9B while lifting full-year guidance.
Special committees of independent directors are reviewing a possible SpaceX-Tesla combination valued around $3.5 trillion.
Be the first to know when deals break, stocks move, or biotech headlines hit.